Key points are not available for this paper at this time.
These findings provide estimates of cancer risk based on BRCA1 and BRCA2 mutation carrier status using prospective data collection and demonstrate the potential importance of family history and mutation location in risk assessment.
Kuchenbaecker et al. (Tue,) studied this question.